Tempus AI, Inc. - Class A Common Stock (NQ: TEM )

39.05 -0.23 (-0.60%)

Streaming Delayed Price Updated: 4:00 PM EDT, Aug 2, 2024 Add to My Watchlist

Price and Volume

Volume	680,750
Open	38.00
Bid (Size)	39.04 (1)
Ask (Size)	39.50 (2)
Prev. Close	39.28
Today's Range	36.11 - 39.48
52wk Range	22.89 - 47.09
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

3 AI-Powered Healthcare Stocks Transforming Medicine

August 02, 2024

Invest in AI healthcare stocks to benefit significantly from tech that could propel the healthcare market to $148.4 billion by 2029.

Via InvestorPlace

7 New Growth Stock Listings That Can Be Long-Term Wealth Creators

August 02, 2024

These are the new growth stocks to buy as they represent under-the-radar companies with sustained growth potential

Via InvestorPlace

Performance

YTD	-2.99%	-2.99%
1 Month	+13.54%	+13.54%
3 Month	-2.99%	-2.99%
6 Month	-2.99%	-2.99%
1 Year	-2.99%	-2.99%

More News

Tempus Next Launches New Algorithm to Close Care Gaps in Guideline-Directed IHC Testing, Starting with HER2

August 01, 2024

From Tempus AI, Inc.

Via Business Wire

Tempus Announces Expanded Data and Sequencing Collaboration with Remix Therapeutics

July 30, 2024

From Tempus AI, Inc.

Via Business Wire

3 AI-in-Healthcare Stocks to Buy for Outsized Returns

July 29, 2024

Via InvestorPlace

7 Growth Stocks That Can Create Millionaires by 2030

July 26, 2024

Via InvestorPlace

Riot Platforms & North Face Parent V.F. Corp Are Among 11 Mid-Cap Stocks That Performed The Best Last Week (July 14-July 20): Are Others In Your Portfolio?

July 21, 2024

Via Benzinga

7 Millionaire-Making Growth Stocks to Buy and Forget

July 18, 2024

Via InvestorPlace

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

July 18, 2024

Via The Motley Fool

Tempus to Report Second Quarter 2024 Financial Results on August 6

July 17, 2024

From Tempus AI, Inc.

Via Business Wire

UnitedHealth Posts Better-Than-Expected Earnings, Joins AngioDynamics, Bank of America And Other Big Stocks Moving Higher On Tuesday

July 16, 2024

Via Benzinga

Tempus Expands Immuno-Oncology Portfolio with Launch of AI-enabled, Multimodal Immune Profile Algorithmic Tests

July 16, 2024

From Tempus AI, Inc.

Via Business Wire

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

July 16, 2024

Via The Motley Fool

3 Under-the-Radar IPO Stocks to Buy Before They Double

July 15, 2024

Via InvestorPlace

IPOs 2024: Tempus AI Addresses Medical Diagnostic Use Case

July 12, 2024

Via Talk Markets

Investor That Backed Moderna Raises $3.6B For AI-driven Biotech Ventures

July 10, 2024

Via Benzinga

Tempus Surpasses 500 Research Publications

July 10, 2024

From Tempus AI, Inc.

Via Business Wire

Tempus AI Has Massive Market Opportunity For This Healthcare Technology, Bullish Analyst Says

July 09, 2024

Via Benzinga

Tempus Could Gain Share In AI Health Care Market Poised To Grow By Over 30%

July 09, 2024

Via Benzinga

American Medical Association Grants PLA Code to Tempus Algorithmic Test, PurISTSM

July 08, 2024

From Tempus AI, Inc.

Via Business Wire

IPO Watch: 3 New Stocks Worth a Strong Look

July 05, 2024

Via InvestorPlace

3 New IPOs That Could Be the Next Big Thing

July 04, 2024

Via InvestorPlace

Why Tempus AI (TEM) Stock Is Rising

July 02, 2024

Via Benzinga

CMS Awards Tempus With Advanced Diagnostic Laboratory Test (ADLT) Status for its xT CDx Test

July 02, 2024

From Tempus AI, Inc.

Via Business Wire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

July 01, 2024

Via InvestorPlace

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.